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Abstract
Physical therapists often treat cancer patients. Cancer treatment includes chemotherapy, 
radiotherapy, and surgery, which are being continuously developed and thus increase 
survival of patients with each cancer diagnosis. More specifically, 5-year survival rates 
increase with each cancer diagnosis. Cancer patients have many problems including 
muscle weakness, pulmonary dysfunction, fatigue, and pain. In the end, patients with 
cancer tend to have a decline in activities of daily living (ADL) and quality of life (QOL). 
Additionally, cancer patients often have progressive disease, depression, and anxiety. 
Physical therapy often helps patients regain strength and physical function and improve 
their QOL and independence of daily living that they may have lost due to cancer or its 
treatment. Physical therapy has an important role in increasing physical function of can-
cer patients, cancer survivors, and children with cancer. In the future, physical therapy 
may be progressively needed for management of cancer patients.
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1. Introduction
Cancer and its treatments are associated with a wide range of distressing physical and psy-
chological symptoms that can affect patients for many years following treatment [1]. Many 
cancer patients also have physical dysfunction and experience deficits in muscle strength, 
flexibility, and endurance as a result of chemotherapy, radiation therapy, and surgery [2]. 
Physical therapy is a comprehensive, multidisciplinary approach to the evaluation and treat-
ment of patients diagnosed with various forms of cancer. Physical therapy can improve func-
tional problems such as weakness, soft tissue tightness, joint stiffness, fatigue, and swelling 
or edema [3, 4]. Physical therapy allows experts to find the best ways for cancer patients to 
stay active. Physical therapy-led exercise is clinically effective and can help cancer patients 
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improve their quality of life (QOL) [5]. Physical therapy includes stretching, strengthening, 
and aerobic exercises for the inpatients, outpatients, and cancer survivors. It often helps 
patients regain strength, physical functioning, quality of life, and independence in activi-
ties of daily living (ADL) that they may have lost due to cancer or its treatment. Physical 
therapists are available in multiple treatment settings, including preoperative, postoperative, 
acute care, nursing home, and inpatient and outpatient rehabilitation. Physical therapists also 
work in conjunction with the rehabilitation team to design components of a survivorship care 
plan in order to optimize overall functional outcomes (Figure 1) [6]. Cancer has four stages, 
and cancer patients have differences in disease and disabilities during each stage (Table 1). 
Physical therapists often use four cancer rehabilitation stages and identify the stage before 
physical therapy for cancer patients (Table 2) [7]. There are different approaches for therapy 
of cancer patients during each stage.
Figure 1. Rehabilitation team for cancer patients.
Stage Characteristics
Stage 1 Cancer is relatively small and contained within the organ it originated from. This stage describes 
cancer in situ, which means “in place.” Stage 1 cancers have not spread to nearby tissues. This stage of 
cancer is often highly curable, usually by removing the entire tumor with surgery
Stage 2 Cancer has not started to spread into surrounding tissue but the tumor is larger than in Stage 1. 
Sometimes, Stage 2 means that cancer cells have spread into lymph nodes close to the tumor. At this 
stage, cancer or tumor is relatively small and has not grown deeply into the nearby tissues. It also has 
not spread to the lymph nodes or other parts of the body. It is often called an early-stage cancer
Stage 3 Cancer is larger. It may have started to spread into surrounding tissues, and cancer cells may be 
present in the lymph nodes of the area. This stage indicates larger cancers or tumors
Stage 4 Cancer has spread from where it started to another organs or parts of the body. This is also called a 
secondary, advanced, or metastatic cancer
Table 1. Cancer stage.
Clinical Physical Therapy96
This chapter introduces overview, treatment, common dysfunctions, physical therapy assess-
ment, physical therapy, key points in diagnosis, and palliative care of following cancer types: 
breast cancer, gynecologic cancers, brain tumor, head and neck cancer, lung cancer, esopha-
gus cancer, bone cancer, and blood cancer. This chapter also shows the important role of 
physical therapy in cancer patients.
2. General concept of physical therapy
Physical therapists must undergo assessment based on the International Classification of Func-
tioning, Disability and Health (ICF) model before, during, and after physical therapy for each 
cancer patient (Figure 2). ICF enables physical therapist to provide cancer patients with therapy. 
Cancer patients have many problems caused by cancer treatment or cancer itself. Physical ther-
apy assessment should include manual muscle testing (MMT), range of motion (ROM), balance 
test, endurance test, and ADL test. Performance status (PS; Table 3) [8], Palliative Performance 
Scale (PPS; Table 4) [9], Barthel index (BI) [10], functional independence measure (FIM) [11, 12], 
and QOL are also used as assessment tools for cancer patients. Physical therapists should be 
aware that cancer patients are exposed to various risks such as infectious diseases due to immu-
nosuppressive effects of the treatment. Thus, physical therapists must manage risks that are 
related to cancer and its treatment (Table 5) [13]. Additionally, physical therapists must recog-
nize that cancer is a progressive disease. In general, cancer patients have a gradual decline in 
their physical function. Once a goal is set, physical therapists must be aware of cancer progres-
sion and patients’ prognosis [14]. Physical therapists also must know a variety of other problems 
that occur in cancer patients. Cancer patients might not only have physical function problems 
but may also develop depression and anxiety in the future [15]. Cancer patients might feel the 
fear of cancer recurrence or death. Physical therapy may be effective in reducing fatigue, increas-
ing muscle strength and exercise capacity, and improving QOL in various cancer patients.
Stage
(1) Preventive
Intervention focused on improving the patient’s level of function prior to the onset of the effects of the cancer and its 
treatment, patient education, and psychological support
(2) Restorative rehabilitation
Intervention focused on returning the patient to a previous level of function and addressing impairments from 
cancer and its treatment
(3) Supportive rehabilitation
Intervention is meant to assist the cancer patient to function at the highest level within the context of his or her 
impairments, activity limitations, and participation restrictions
(4) Palliative rehabilitation
Intervention focused on minimizing complications such as pressure ulcers, contractures, and muscle deconditioning 
ensuring adequate pain control and emotional support for the family
Table 2. Four cancer rehabilitation stages.
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Figure 2. International Classification of Functioning, Disability, and Health.
Grade ECOG performance status
0 Fully active, able to carry on all pre-disease performance without restriction
1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or 
sedentary nature, e.g., light house work, office work
2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more 
than 50% of waking hours
3 Capable of only limited self-care, confined to bed or chair more than 50% of waking hours
4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair
5 Dead
Table 3. Performance status (PS).
PPS level Ambulation Activity and evidence 
of disease
Self-care Intake Conscious level
100 Full Normal activity and 
work no evidence of 
disease
Full Normal Full
90 Full Normal activity and 
work
Some evidence of 
disease
Full Normal Full
80 Full Normal activity with 
effort Some evidence 
of disease
Full Normal or reduced Full
70 Reduced Unable normal job/
work Significant 
disease
Full Normal or reduced Full
60 Reduced Unable hobby/house 
work Significant 
disease
Occasional 
assistance 
necessary
Normal or reduced Full or confusion
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PPS level Ambulation Activity and evidence 
of disease
Self-care Intake Conscious level
50 Mainly sit/lie Unable to do any work 
Extensive disease
Considerable 
assistance required
Normal or reduced Full or confusion
40 Mainly in bed Unable to do most 
activity Extensive 
disease
Mainly assistance Normal or reduced Full or drowsy ± 
confusion
30 Totally bed 
bound
Unable to do any 
activity Extensive 
disease
Total care Normal or reduced Full or drowsy ± 
confusion
20 Totally bed 
bound
Unable to do any 
activity Extensive 
disease
Total care Minimal to sips Full or drowsy ± 
confusion
10 Totally bed 
bound
Unable to do any 
activity Extensive 
disease
Total care Mouth care only Drowsy or coma 
± confusion
0 Death
1PPS scores are determined by reading horizontally at each level to find a “best fit” for the patient who is then assigned 
as the PPS% score.
2Begin at the left column, read downward until the appropriate ambulation level is reached, and then read across to the 
next column and downward again until the activity/evidence of disease is located. These steps are repeated until all five 
columns are covered before assigning the actual PPS for that patient. In this way, “leftward” columns (columns to the left 
of any specific column) are “stronger” determinants and generally take precedence over others.
3PPS scores are in 10% increments only. Sometimes, there are several columns easily placed at one level but one or two 
which seem better at a higher or lower level. One then needs to make a “best fit” decision. Choosing a “halfwit” value 
of PPS 45%, for example, is not correct. The combination of clinical judgment and “leftward precedence” is used to 
determine whether 40% or 50% is the more accurate score for that patient.
Table 4. Palliative Performance Scale (PPSv2).
1. Hematologic profile: hemoglobin <7.5 g, platelets <20,000, white blood cell count <3000
2. Metastatic bone disease
3. Compression of a hollow viscous (bowel, bladder, or ureter) vessel or spinal cord
4. Fluid accumulation in the pleura, pericardium, abdomen, or retroperitoneum associated with persistent pain, 
dyspnea, or problems with mobility
5. CNS depression or coma or increased intracranial pressure
6. Hypokalemia/hyperkalemia, hyponatremia, or hypocalcemia/hypercalcemia
7. Orthostatic hypotension
8. Heart rate in excess 110 beat/min or ventricular arrhythmia
9. Fever greater than 101°F
Table 5. Precaution rehabilitation for cancer patients.
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3. Physical therapy in cancer patients
3.1. Breast cancer
3.1.1. Overview
Breast cancer is the most common invasive cancer in women worldwide [16]. Breast cancer 
alone accounts for 25% of all cancer cases and 15% of all cancer deaths among women [17]. 
Breast cancer starts when cells in the breast begin to grow out of control. These cells usually 
form a tumor that can be often seen on an X-ray or felt as a lump. Breast cancer can develop 
following changes in genetic material leading to cellular changes that causes cells to start 
multiplying in an uncontrolled fashion, forming lumps or nodules.
3.1.2. Treatment
In general, breast cancer patients have few treatment options such as surgery (breast-
conserving surgery and mastectomy), radiation therapy, chemotherapy, and hormone 
therapy [18, 19]. In some cases, lymph nodes located close to the affected breast need to be 
surgically removed.
3.1.3. Common dysfunctions in breast cancer
Muscle weakness around the shoulder joint, decline of ADL using upper extremities, dizziness, 
loss of appetite, shortness of breath, depression are present in a substantial majority of patients 
during or after their initial treatment (surgery, radiation, and/or chemotherapy) [20, 21]. Physical 
therapists must pay attention to the occurrence of musculoskeletal disorders and lymph vas-
cular disorders following breast surgery. Musculoskeletal disorders include postsurgical pain, 
rotator cuff disease, and adhesive capsulitis [22]. Lymph vascular disorders are common after 
removal of lymph nodes [23]. As a result, breast cancer patients have limited range of motion, 
muscle weakness, pain, and ADL decline such as difficulties while brushing hair or taking off 
the jacket. In some cases of breast cancer, cellulitis occurs that can become a potentially serious 
bacterial skin infection [21, 24].
3.1.4. Physical therapy assessment
Physical therapy assessment of cancer patients includes the ICF, examination of shoulder 
ROM, MMT, pain levels, fatigue, upper limb volume, an upper limb disability questionnaire, 
and QOL evaluation. Additionally, in the cases of breast cancer patients, physical therapists 
assess exercise tolerance.
3.1.5. Physical therapy
Many previous studies showed that physical therapy has effectiveness in breast cancer patients 
[25, 26]. In general, combined physical therapy is effective to treat postoperative lymphedema, 
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pain, and impaired ROM after treatment for breast cancer [26]. Physical therapy for breast 
cancer patients includes lymphatic drainage massage, vantage, manual stretching, myofascial 
therapy, relaxation massage, stretching, strengthening, resisted exercise, proprioceptive neu-
romuscular facilitation (PNF) exercises, isometric exercises, aerobic exercises, transcutaneous 
electrical nerve stimulation (TENS), heat and cold, patient education, and behavioral training. 
Breast cancer patients also receive ADL training such as bathing, showering (washing the 
body), and dressing.
3.1.6. Key points
Physical therapists should improve mobility of upper extremities with a reduction of their 
volume. This should be followed by an attempt to recover upper limb function in ADL.
3.2. Gynecologic cancers
3.2.1. Overview
Gynecologic cancers accounted for 19% of the 5.1 million estimated new cancer cases and 13 
million 5-year prevalent cancer cases among women in the world in 2002 [27]. Gynecologic 
cancer is described as the uncontrolled growth and spread of abnormal cells originating in 
the female reproductive organs. They are found in different places within a woman’s pelvis, 
which is the area below the stomach and in between the hip bones. Five main types of gyne-
cologic cancers are present: cervical, ovarian, uterine, vaginal, and vulvar.
3.2.2. Treatment
In general, gynecologic cancers can be cured with aggressive treatment involving surgery, 
chemotherapy, and/or radiation. Treatment goal in recurrent and metastatic cancer is to 
decrease progression of the disease [28, 29].
3.2.3. Common dysfunctions in gynecologic cancer
Weakness of pelvic floor muscles, decline in ADL, dizziness, loss of appetite, shortness of 
breath, depression are the symptoms present in a substantial majority of patients during or 
after their initial treatment (surgery, radiation, and/or chemotherapy) [30]. Lower extremity 
weakness often occurs in gynecologic cancer patients; thus, locomotion disability is common 
[31]. Physical therapists must pay attention to occurrence of musculoskeletal and lymph vas-
cular disorders at the lower extremities following gynecologic surgery [32]. Lymphovascular 
disorders cause problems after removal of lymph nodes [33]. As a result, patients experience 
limited ROM, muscle weakness, pain, and decline in ADL.
3.2.4. Physical therapy assessment
First, physical therapists should assess pelvic floor muscle strength as gynecologic cancers 
have urinary incontinence after the treatment [34, 35]. Second, physical therapists should 
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assess ICF category: lower extremities such as hip, knee, and ankle ROM; MMT; assessment 
of pain levels; fatigue; upper limb volume; locomotion ability such as gait speed; balance 
function; QOL; ADL; and sexual function [36]. Additionally, physical therapists should assess 
exercise tolerance.
3.2.5. Physical therapy
A few previous reports showed that physical therapy has a positive effect on gynecologic 
cancer patients [37]. Physical therapists should perform pelvic floor physical therapy as a 
tool to aid in addressing pelvic floor symptoms [37]. In general, physical therapy for gyne-
cologic cancer patients includes locomotion ability exercises such as standing and walking, 
lymphatic drainage massage, vantage, manual stretching, myofascial therapy, relaxation 
massage, stretching, strengthening, resisted exercise, PNF, aerobic exercise, TENS, patient 
education, and behavioral training.
3.2.6. Key points
Physical therapists should improve muscle strength of lower extremities and reduce their 
volume as soon as possible. This should be followed by acquiring locomotion.
3.3. Brain tumor
3.3.1. Overview
The worldwide cancer incidence of a malignant brain tumor is 3.4 per 100,000 for men and 3.0 
per 100,000 for women [38]. Brain tumor is the most common neurological complication related 
to cancer [39]. Brain tumors can originate from the patient’s brain (primary brain tumors) or 
from other parts of the patient’s body (secondary or metastatic brain tumors) [40, 41]. Brain 
tumors can destroy brain cells, increase inflammation, and elevate brain pressure. Brain tumors 
may cause a wide range of neurological dysfunctions, including disorders of the nervous 
system.
3.3.2. Treatment
In general, treatment options include surgery, radiation therapy, chemotherapy, targeted bio-
logical agents, or a combination of these [42]. Surgical resection is commonly the first recom-
mended treatment in order to rapidly reduce brain pressure.
3.3.3. Common dysfunctions in brain tumor
Brain tumor patients commonly experience weakness, sensory loss, and abnormal muscle 
tone. These include spasticity, visuospatial deficits, hemi-neglect or bilateral visual deficits, 
ataxia, cognitive deficits (thought processes, memory changes, apraxia, etc.), speech difficul-
ties, dysphagia, bowel and bladder dysfunction, psychological problems, and fatigue. As a 
result, ADL decline and lower QOL are common in brain tumor patients [43, 44].
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3.3.4. Physical therapy assessment
Physical therapists often assess ICF category, Glasgow Coma Scale, Mini-Mental State Exam-
ination, Fugl-Meyer, Motor Assessment Scale, Motricity Index, Berg Balance Assessment, Beck 
Depression Inventory (BDI), and Hospital Anxiety and Depression Scale (HADS). They examine 
pain levels and locomotion ability such as gait speed, QOL, and sexual function. Additionally, 
physical therapists should assess exercise tolerance in brain tumor patients [45, 46].
3.3.5. Physical therapy
To date, no previous study has reported positive effects of physical therapy in adult brain 
tumor patients. However, a few reports showed that physical therapy may be effective in 
pediatric brain tumor patients [47]. In general, physical therapy performed in brain tumor 
patients is also performed in stroke patients [48]. It includes neurofacilitation techniques such 
as Bobath, PNF, Brunnstrom, motor relearning, functional electrical stimulation (FES), bio-
feedback, balance retraining, gait reeducation, and use of supportive equipment. Physical 
therapists must be aware of the progress of paralysis in brain tumor patients as a result of 
increasing tumor size. Physical therapists should know how to improve convalescence of the 
brain. Additionally, cognitive dysfunction, apraxia, and aphasia should be assessed [49].
3.3.6. Key points
Physical therapists should aim to treat paralysis and improve ADL as soon as possible. 
Attention should be paid to progressive paralysis in brain tumor patients.
3.4. Head and neck cancer
3.4.1. Overview
Overall, the annual incidence of head and neck cancer worldwide is more than 550,000 cases 
with around 300,000 deaths [50]. Men are affected significantly more than women [51]. Head 
and neck cancer includes cancers of the mouth, nose, sinuses, salivary glands, throat, and 
lymph nodes in the neck. Most originate from the moist tissues that line the mouth, nose, and 
throat. Head and neck cancers can also originate within the salivary glands. Salivary glands 
contain many different types of cells that can become cancerous leading to many different 
types of salivary gland cancers.
3.4.2. Treatment
Treatment options include surgery, radiation therapy, chemotherapy, and targeted therapy 
[52]. Surgery or radiation therapy alone or a combination of these treatments may be part of 
a patient’s treatment plan [53]. Tracheostomy is performed when there are concerns about 
breathing due to airway obstruction associated with a throat cancer or treatment side effects 
[54]. Nutritional status of patients declines following tracheostomy. As patients are not able 
to eat, they usually receive intravenous feeding.
Physical Therapy in Patients with Cancer
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3.4.3. Common dysfunctions in head and neck tumor
Aspiration pneumonia after concurrent chemoradiation therapy and surgery is seen in 
head and neck cancer patients [55]. Most patients have dysphagia and are at increased 
risk of having aspiration and subsequent pneumonia [56]. Additionally, physical thera-
pists must be aware of the decline in nutritional status after surgery or chemoradiation in 
these patients [57]. Paralysis of accessory nerve that causes trapezius muscle dysfunction 
is often seen following neck dissection [58]. This dysfunction leads to shoulder syndrome 
with adhesive capsulitis. Muscle weakness, decline of ADL, dizziness, loss of appetite, 
shortness of breath, depression are observed in a substantial majority of patients dur-
ing or after their initial treatment (surgery, radiation, and/or chemotherapy) [59]. Upper 
and lower extremities tend to be weaker following long-term bedridden and sedentary 
treatment.
3.4.4. Physical therapy assessment
General pulmonary function tests are performed: spirometry; breathing pattern and cough; 
breath sounds including wheezing, coarse crackles, fine crackles, and rhonchi; and posture 
deformities in the chest or the spine; dysphagia evaluation; and ADL. Additionally, physical 
therapists should perform exercise tolerance test in gynecologic cancer patients. Furthermore, 
physical therapists should assess shoulder function including strength, mobility, and pain 
after surgery or chemoradiotherapy. Physical therapists often assess ICF category and lower 
and upper joint ROM; perform MMT; and evaluate pain levels, fatigue, and locomotion abil-
ity such as gait speed, balance function, and QOL.
3.4.5. Physical therapy
Physical therapy of the arms is performed to improve locomotion and pulmonary dysfunc-
tion. Some previous reports showed that physical therapy has effectiveness in head and 
neck cancer patients [60, 61]. When patients have paralysis of the accessory nerve, phys-
ical therapists perform exercises for the trapezius muscle to reduce its dysfunction [62]. 
Additionally, physical therapy of head and neck cancer patients includes locomotion ability 
exercises such as standing and walking, massage, manual stretching, myofascial therapy, 
relaxation massage, stretching, strengthening, resisted exercise, PNF, aerobic exercise, 
TENS, patient education, and behavioral training [63, 64]. However, if patients are fasting 
and have aspiration, they may have lower nutritional status requiring physical function 
recovery to be delayed.
3.4.6. Key points
Physical therapists must recognize that head and neck cancer patients tend to experience 
decline of the pulmonary function and paralysis of accessory nerve following the neck sur-
gery. Physical therapists should recover pulmonary and shoulder function and improve ADL 
in such patients.
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3.5. Lung cancer
3.5.1. Overview
Lung cancer is the most frequently diagnosed cancer worldwide with about 1.35 million new 
cases diagnosed each year [65]. Lung cancer starts with uncontrollable growth of abnormal 
cells in the lung. These cells can invade nearby tissues and form tumors. Lung cancer can start 
anywhere in the lungs and affect any part of the respiratory system. Cancer cells can spread, 
or metastasize, to the lymph nodes and other parts of the body. There are two main types of 
lung cancer: small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). Small-
cell lung cancers usually grow quicker and are more likely to spread to other body parts. 
Non-small-cell lung cancer accounts for about 85% of all lung cancer cases, whereas small-cell 
lung cancer accounts for about 15% of all lung cancer cases [50, 66].
3.5.2. Treatments
Lung cancer treatment depends on its type. Small-cell lung cancer is mostly treated with 
chemotherapy [67]. Non-small-cell lung cancer can be treated with surgery, chemotherapy, 
radiotherapy, or a combination of these depending on the stage at which the cancer is diag-
nosed [68, 69].
3.5.3. Common dysfunctions in lung cancer
When lung cancer treatment involves chemotherapy only, patients experience a decrease in 
physical function including decreased muscle strength and flexibility, which is also observed 
before the treatment. However, if lung cancer patients receive surgery, they encounter more 
problems than without the surgery. These problems include pulmonary dysfunction and 
decline of locomotion and ADL. Additionally, lung cancer patients experience pain of a surgi-
cal wound following thoracotomy and costectomy. Muscle weakness, decline of ADL, diz-
ziness, loss of appetite, shortness of breath, and depression occur in a substantial majority 
of patients during or after their initial treatment (surgery, radiation, and/or chemotherapy). 
Upper and lower extremity and trunk muscle strength decreases following long-term bedrid-
den and sedentary treatment.
3.5.4. Physical therapy assessment
General pulmonary function tests include spirometry; breathing pattern and cough; breath 
sounds like wheezing, coarse crackles, fine crackles, and rhonchi; postural deformities in 
the chest or the spine; and dysphagia evaluation on ADL [70, 71]. Additionally, physical 
therapists should assess exercise tolerance and shoulder function including its strength, 
mobility, and pain following surgery or chemoradiotherapy in patients with lung cancer. 
Physical therapists often assess ICF category and lower and upper joint ROM; perform 
MMT; and assess pain levels, fatigue, and locomotion ability such as gait speed, balance 
function, and QOL.
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3.5.5. Physical therapy
Physical therapy of the arms is done in order to improve locomotion and pulmonary dys-
function after the treatment [72]. Some previous studies reported that preoperative physical 
therapy has effectiveness in lung cancer patients [73, 74]. Intensive physical therapy appears 
to increase oxygen saturation, reduce hospital stay, and change ventilation/perfusion distri-
bution in lung cancer patients [73]. Following surgery with resection, physical therapists pro-
mote mobilization starting at the intensive care unit (ICU) because lung cancer patients tend 
to be sedentary leading to progressive decline in their physical function. Physical therapy 
for lung cancer patients includes massage, manual stretching, myofascial therapy, relaxation 
massage, stretching, strengthening, resisted exercise, PNF, aerobic exercise, TENS, patient 
education, and behavioral training.
3.5.6. Key points
Physical therapists should prevent development of further weakness after the treatment. 
Following surgery, physical therapists must make lung cancer patients perform pulmonary 
and mobilization exercises as soon as possible.
3.6. Esophageal cancer
3.6.1. Overview
Esophageal carcinoma affects more than 450,000 people worldwide, and the incidence is rap-
idly increasing [75]. Esophageal cancer is a disease in which malignant (cancer) cells form in 
the tissues of the esophagus. The most common types of esophageal cancer are squamous cell 
carcinoma and adenocarcinoma. Smoking and heavy alcohol use increase the risk of esoph-
ageal squamous cell carcinoma [76]. Esophageal cancer is often diagnosed at an advanced 
stage because there are no early signs or symptoms. A cancerous tumor is malignant, meaning 
it can grow and spread to other parts of the body. Esophageal cancer can also spread into the 
lungs, liver, stomach, and other parts of the body.
3.6.2. Treatment
Chemotherapy, radiotherapy, and surgery are often used as treatments for esophageal can-
cers [77]. Chemotherapy by itself rarely is effective. It is often combined with radiation ther-
apy. Chemoradiation is often used before the surgery aiming to remove the cancer and some 
of the normal surrounding tissues. In some cases it might be combined with other treatments, 
such as chemotherapy and/or radiation therapy [78].
3.6.3. Common dysfunctions in esophageal cancer
If esophageal cancer patients receive chemotherapy or radiotherapy alone, they tend to have 
decreased physical function including loss of muscle strength and flexibility which is also 
observed before treatment. However, if surgery is performed, patients have more problems 
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than without surgery, including pulmonary dysfunction and decline of locomotion and ADL. 
Following surgery, patients have to stay in ICU for few days. During this period, patients 
may develop a decline in pulmonary function and as a result, they may be intubated for a 
long time. Additionally, fasting is common for a few weeks until patients can eat food without 
aspiration. Muscle weakness, decline of ADL, dizziness, loss of appetite, shortness of breath, 
depression are observed in a substantial majority of patients during or after their initial treat-
ment (surgery, radiation, and/or chemotherapy). Upper and lower extremity and trunk mus-
cle strength decreases following long-term bedridden and sedentary treatment.
3.6.4. Physical therapy assessment
General pulmonary function tests should be performed in cancer patients. This includes 
spirometry; breathing pattern and cough; breath sounds like wheezing, coarse crackles, fine 
crackles, and rhonchi; and postural deformities in the chest or the spine. Evaluation of dys-
phagia on ADL should be also often assessed. Additionally, physical therapists should assess 
exercise tolerance in esophageal cancer patients and shoulder function including strength, 
mobility, and pain after surgery or chemoradiotherapy in patients with esophageal cancers. 
Physical therapists often assess ICF category and lower and upper joint ROM; perform MMT; 
and assess pain levels, fatigue, and locomotion ability such as gait speed, balance function, 
and QOL [79].
3.6.5. Physical therapy
To date, there are no previous studies reporting that physical therapy is effective in esophageal 
cancer patients. In general, physical therapy has few aims in these patients. First, performance 
of pulmonary exercises including positioning and breathing exercises promotes weaning of 
the ventilator and extubating. Second, improvement of locomotion promotes mobilization in 
patient’s bedside [80]. Third, physical therapy aims to improve muscle strength and exercise 
tolerance during hospitalization. Physical therapy often includes massage, manual stretch-
ing, myofascial therapy, relaxation massage, stretching, strengthening, resisted exercise, PNF, 
aerobic exercise, TENS, patient education, and behavioral training.
3.6.6. Key points
Physical therapists should aim to prevent further weakness after the treatment. Following 
surgery, physical therapists must make patients perform pulmonary exercise and mobiliza-
tion as soon as possible.
3.7. Bone cancer
3.7.1. Overview
The age-adjusted incidence rate of primary malignant bone tumors in the United States is 
0.9 per 100,000 persons per year, accounting for approximately 0.2% of all malignancies [81]. 
Bone cancer is a rare form of cancer that can affect any bone in the body. Bone cancer is a 
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 cancer that arises from the cells that make up the bones. When cancer is detected in the bone, 
it most often has started somewhere else (e.g., in another organ) and then spread to the bones. 
This is known as cancer that has metastasized to the bone and is named after the site where 
the original cancer began. Bone cancer can vary widely from person to person depending on 
its location and size. The most common type of malignant bone tumor is osteosarcoma, which 
most often develops in the bones of the arms, legs, and pelvis. Other types of bone cancer 
include the following: chondrosarcoma, Ewing’s tumor, chordoma, fibrosarcoma, giant cell 
tumor, and malignant fibrous histiocytoma [82].
3.7.2. Treatment
Treatment includes surgery, chemotherapy, and radiation therapy [83, 84]. Amputation may 
be necessary if limb-sparing surgery is not possible or had no positive outcomes [85].
3.7.3. Common dysfunctions in bone cancer
Chemotherapy or radiotherapy alone results in and improvement of physical function includ-
ing muscle strength and flexibility. However, if bone cancer patients received surgery, they 
could develop some problems. Patients may have pain and weakness of the affected limb and 
may have restricted weight bearing and movement of limbs or the spine. In addition, when 
amputation of the arm, leg, hand, or foot is performed, patients become more physically 
disabled. Bone cancer patients with spine tumor, paraplegia, or quadriplegia have declined 
motor and sensory function in addition to bladder and bowel dysfunction [86].
3.7.4. Physical therapy assessment
Physical therapists should often assesses ICF category; pain levels; affected bone tumor; 
ROM; MMT; fatigue; ADL; and locomotion ability such as gait speed, balance function, and 
QOL. Physical therapists should be aware of motion and weight-bearing restrictions that 
occur after the surgery. In case of amputation, physical therapists should assess phantom 
limb pain, muscle strength, and mobility of the affected limb. Patients with spine tumor 
have paralysis; hence, physical therapists should use the American Spinal Injury Association 
(ASIA) scores for evaluation of sensory function, strength, mobility, and pain after the surgery 
or chemoradiotherapy.
3.7.5. Physical therapy
To date, there are no previous studies reporting that physical therapy is effective in bone can-
cer patients. In general, physical therapists must pay attention to fragile bones. Bone tumors 
make bones easy to fracture with vigorous movements. Physical therapy differs depending 
on the treatment of bone cancer. When bone cancer patients receive chemotherapy and radio-
therapy only, muscle strengthening and endurance exercises are performed. However, when 
patients receive surgery, physical therapists must pay attention to contraindicative exercises. 
When patients receive amputation, limb prosthetics should be considered by the physiothera-
pist together with a prosthetist and an orthotist. In bone cancer patients with paraplegia such 
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as bone tumor in the spinal cord, physical therapy is carried out in accordance with physical 
therapy of spinal cord injury. Otherwise, physical therapy often includes stretching, strength-
ening, resisted exercise, PNF, aerobic exercise, patient education, and behavioral training.
3.7.6. Key points
Physical therapists must know the location and progression of bone tumor as it is an impor-
tant factor allowing improvement of physical function after treatment.
3.8. Blood cancer including hematopoietic stem cell transplantation (HSCT)
3.8.1. Overview
The number of new cases of leukemia is 4.5–9.1 per 100,000 men and 3.6–6.0 per 100,000 
women per year [50]. Blood cancer affects the blood and lymph systems. Bone marrow has 
a function of producing blood cells such as red blood cells, white blood cells, and platelets. 
Bone marrow is a flexible soft tissue found in the hollow interior of the bones. Blood cancer 
may begin in blood-forming tissue (e.g., bone marrow) or in the cells of the immune system. 
There are different types of hematological cancers including leukemia, non-Hodgkin lym-
phoma, Hodgkin lymphoma, and multiple myeloma. Leukemia is a cancer that originates in 
the white blood cells and affects people of all ages [87].
3.8.2. Treatment
In general, blood cancer treatment includes chemotherapy, corticosteroids, radiation, and 
HSCT.
3.8.3. Common dysfunctions in blood cancer
First, blood cancer patients that have received chemotherapy experience a decrease in physi-
cal function including muscle strength and endurance capacity. Second, if complete remission 
is not achieved after chemotherapy, HSCT has to be chosen. In this case, patients experi-
ence even more decreased muscle strength and endurance capacity as they have to stay in a 
hospital for a few weeks [88, 89]. Hospitalized patients often have graft-versus-host disease 
(GVHD). GVHD normally affects the skin, liver, and gastrointestinal system resulting in fur-
ther dysfunctions. Furthermore, following HSCT treatment, patients must stay in the isola-
tion room to prevent infection; hence, a decrease in physical activity during these days will 
occur [90].
3.8.4. Physical therapy assessment
Physical therapists should assess muscle strength, body composition, mobility, and endur-
ance capacity in blood cancer patients. Physical therapists often assess ICF category, lower 
and upper joint ROM, balance function, MMT, fatigue, and locomotion ability such as gait 
speed, balance function, and QOL [91–94].
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3.8.5. Physical therapy
Physical therapy focused on the arms is performed in order to improve locomotion and mus-
cle strength after treatment. Some previous reports showed that physical therapy is effec-
tive in pediatric leukemia patients [95, 96]. Additionally, some previous reports showed that 
physical therapy is effective in patients with HSCT [90, 97]. Following HSCT, physical thera-
pists must wear a mask, plastic grove, and apron during physical therapy. The most common 
physical therapy of blood cancer includes massage, manual stretching, myofascial therapy, 
relaxation massage, stretching, strengthening, resisted exercise, PNF, aerobic exercise, bal-
ance training, TENS, patient education, and behavioral training.
3.8.6. Key points
Physical therapists should aim to increase muscle strength and exercise capacity in blood can-
cer patients. Additionally, physical therapists must be aware that patients may have myelo-
suppression as a result of chemotherapy. Physical therapy should be performed in such a way 
that it prevents infection in these patients.
3.9. Palliative care in cancer
Palliative care helps people cope with the symptoms of cancer and cancer treatment [98]. 
Palliative care aims to improve the quality of life of patients who have serious or life-
threatening diseases [99]. The goal of palliative care is to prevent or treat the symptoms 
and side effects of the disease and its treatment in addition to related psychological, social, 
and spiritual problems [100]. However, the main goal is not to cure patients [101]. When 
many different treatments have been tried and showed no control over cancer, it could be 
the time to weigh the benefits and risks of continuing trying new treatments. Palliative care 
provides patients of any age or disease stage with relief from symptoms, pain, and stress 
and should be provided along curative treatment. Palliative care focuses on helping people 
get relief from symptoms caused by serious illness (e.g., nausea, pain, fatigue, or shortness 
of breath) [102].
3.9.1. Treatment
Palliative treatment is designed to relieve symptoms and often includes medication, nutri-
tional support, relaxation techniques, spiritual support, emotional support, and other thera-
pies [103, 104]. Palliative treatment improves patient’s quality of life. It can be used at any 
stage of an illness and also if there are troubling symptoms such as pain or sickness. Palliative 
treatment can also mean using medicines to reduce or control side effects of cancer treatments.
3.9.2. Common dysfunctions in palliative care in cancer patients
Cancer patients have many problems making palliative care a good additional treatment 
option. Patients have many symptoms including pain, fatigue, loss of appetite, nausea, 
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vomiting, shortness of breath, insomnia, thirst, dry mouth, bad taste, and difficulty swal-
lowing. Gradually, patients may become bedridden and sedentary. Patients usually have 
a bigger decrease in muscle strength, pulmonary function, ADL, and locomotion after they 
received palliative care. In some cases, cancer patients have lymphedema. Unfortunately, 
patients may die in a few weeks or months.
3.9.3. Physical therapy assessment
Physical therapists should often assess ICF category, pain levels, ROM, MMT, fatigue, ADL, 
and QOL. Additionally, physical therapists should perform pulmonary function tests includ-
ing spirometry; breathing pattern; cough; breath sounds such as wheezing, coarse crackles, 
fine crackles, and rhonchi; and postural deformities in the chest or the spine and evaluate 
dysphagia on ADL. If cancer patients become bedridden for a long time, physical therapists 
should assess pressure ulcers at the sacrum and coccyx.
3.9.4. Physical therapy
A few previous reports showed that physical therapy may be effective in cancer patients who 
receive palliative care [105, 106]. In general, physical therapy helps to maintain mobility and 
improves body movements [7, 107]. Physical therapists improve locomotion ability by exer-
cises that include standing and walking, massage, manual stretching, strengthening, resisted 
exercises, aerobic exercises, patient education, and behavioral training. If patients have severe 
pain related to cancer, physical therapy includes myofascial therapy, relaxation massage, 
TENS, heat and cold, and positioning. If patients are bedridden or sedentary for a long time, 
physical therapists should relieve pressure to prevent pressure ulcers on bones such as the 
sacrum and coccyx.
3.9.5. Key points
Physical therapists must be aware that cancer patients experience more fatigue and pain 
while improving their locomotion. When cancer patients cannot receive progressive physical 
therapy, physical therapists should use myofascial therapy, relaxation massage, TENS, heat 
and cold, and positioning to relieve pain.
4. Summary and conclusion
Cancer patients have some physical impairment. Physical therapy is helpful and contributes 
to patients’ recovery. Cancer patients are exposed to some risk factors during physical ther-
apy. Therefore, physical therapists must pay attention and manage those risk factors. Cancer 
survivors increase 5 years of survival in various cancer diseases. Physical therapy may have 
an important role to improve physical function, ADL, and QOL of cancer patients and cancer 
survivors.
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